Free Thyroxine Levels During the First Weeks of Life and Neurodevelopmental Outcome Until the Age of 5 Years in Very Preterm Infants
- 1 September 2002
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 110 (3) , 534-539
Abstract
Background. We have conducted a randomized trial with thyroxine (T4) in 200 infants 4 treatment was associated with better 5-year outcome in infants 4) levels Methods. For each infant, the average FT4 of 5 scheduled measurements was calculated between day 3 and day 28. Infants of the placebo and the T4 group separately were divided in 2 groups. The placebo group consisted of a group of infants with average FT4 in the lowest quartile and a group in the upper 75%. The T4 group consisted of a group of infants with average FT4 in the upper quartile and a group in the lower 75%. Developmental outcome (mental/cognitive, motor, and neurologic) at 2 and 5.7 years was compared between high and low FT4 groups, and then compared separately for the T4 and placebo group. Results. In the placebo group, low FT4 was associated with worse outcome on all domains at both time points. After correction for confounding variables, mental and neurologic outcome remained significantly different at 2 years, and motor outcome at 5 years. In the T4 group, high FT4 was not associated with worse outcome, neither at 2 nor at 5 years. Conclusions. In untreated infants, low FT4 values during the first 4 weeks after birth in infants born at 4-treated infants, high FT4 is not associated with worse outcome. Other factors than high FT4 concentrations must play a role in the worse outcome of the T4-treated group of 29 weeks’ gestational age.Keywords
This publication has 33 references indexed in Scilit:
- Effects of Thyroxine Supplementation on Neurologic Development in Infants Born at Less Than 30 Weeks' GestationNew England Journal of Medicine, 1997
- Low thyroxinaemia occurs in the majority of very preterm newbornsEuropean Journal of Pediatrics, 1996
- Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatmentThe Journal of Clinical Endocrinology & Metabolism, 1996
- Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.Journal of Clinical Investigation, 1995
- Reference ranges for newer thyroid function tests in premature infantsThe Journal of Pediatrics, 1995
- Motor and cognitive development in children with congenital hypothyroidism: A long-term evaluation of the effects of neonatal treatmentThe Journal of Pediatrics, 1994
- Transient hypothyroxinaemia associated with developmental delay in very preterm infants.Archives of Disease in Childhood, 1992
- Maternal-Fetal Transfer of Thyroxine in Congenital Hypothyroidism Due to a Total Organification Defect or Thyroid AgenesisNew England Journal of Medicine, 1989
- SERUM CONCENTRATIONS OF THYROTROPIN, THYROID HORMONES AND THYROID HORMONE BINDING PROTEINS DURING ACUTE AND RECOVERY STAGES OF IDIOPATHIC RESPIRATORY DISTRESS SYNDROMEActa Paediatrica, 1979
- Thyroid function in the preterm infant: A longitudinal assessmentThe Journal of Pediatrics, 1978